Regency Centers director granted 167 shares
BLANKENSHIP C RONALD reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BLANKENSHIP C RONALD reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director C. Ronald Blankenship received a grant of 167 shares of Common Stock on August 7, 2026, as director's fees paid in stock under Regency's Omnibus Incentive Plan. After this stock-based fee award, he directly holds 114,923 shares of Regency Centers common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 167 | -- | -- |
Footnotes (1)
- F1. Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan.
Key Figures
Key Terms
Omnibus Incentive Plan financial
director's fees financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did REG report for director C. Ronald Blankenship?
Was the REG Form 4 transaction a stock grant or a market purchase?
What does the footnote on the REG Form 4 transaction explain?
Is the Regency Centers (REG) insider transaction reported as direct or indirect ownership?
AI-generated analysis. How Rhea-AI works. Not financial advice.